Overdose of venlafaxine--a new antidepressant
Adesanya, A.; Varma, S.L.
Medical Journal of Australia 167(1): 54
1997
ISSN/ISBN: 0025-729X PMID: 9236764 Document Number: 480653
Document emailed within 1 workday
Related Documents
Benedetti, F.; Radaelli, D.; Bernasconi, A.; Dallaspezia, S.; Colombo, C.; Smeraldi, E. 2009: Changes in medial prefrontal cortex neural responses parallel successful antidepressant combination of venlafaxine and light therapy Archives Italiennes de Biologie 147(3): 83-93Czartorysky, B.; Harding, J. 1988: QRS interval in tricyclic antidepressant overdose Journal of Clinical Psychiatry 49(11): 456-457
Balfour, P. 2000: Use of hypericum as antidepressant. Safety in overdose needs to be established Bmj 320(7242): 1142-1143
Jarvis, M.R. 1991: Clinical pharmacokinetics of tricyclic antidepressant overdose Psychopharmacology Bulletin 27(4): 541-550
Reed, S.; Schwartz, K.M. 1978: Medical grand rounds: Tricyclic antidepressant (TCA) overdose Journal of the Tennessee Medical Association 71(2): 108
Heaps, T.; Hoye, S.; Roy, R. 2009: Tricyclic Antidepressant Overdose causing Acute Respiratory Distress Syndrome Acute Medicine 8(2): 75-77
Soravisut, N.; Rattanasalee, P.; Junkuy, A.; Thampitak, S.; Sribanditmongkol, P. 2011: Comparative analysis of pathological and toxicological features of opiate overdose and non-overdose fatalities Journal of the Medical Association of Thailand 94(12): 1540-1546
McCombs, J.S.; Nichol, M.B.; Stimmel, G.L.; Sclar, D.A.; Beasley, C.M.; Gross, L.S. 1990: The cost of antidepressant drug therapy failure: a study of antidepressant use patterns in a Medicaid population Journal of Clinical Psychiatry 51 Suppl: 60-69; Discussion: 70-71
Sierra Santos, L.; Raigal Martín, Y.; Ortega García, A.; Barriochoa Martínez de Pisón, C.; Aparicio Jabalquinto, G. 1999: Venlafaxine and its discontinuation syndrome Atencion Primaria 24(10): 617-618
Ahmad, S. 1995: Venlafaxine and severe tinnitus American Family Physician 51(8): 1830
Patel, S. 2006: Fatal Venlafaxine poisoning: Case Report Acute Medicine 5(2): 63-64
Yaba, G.; Sezer, Z.; Tekol, Y. 2006: Interaction between venlafaxine and caffeine on antinociception in mice Die Pharmazie 61(1): 60-62
Jhirwal, O.P.; Chakrabarti, S. 2003: Venlafaxine withdrawal in organic anxiety disorder Indian Journal of Medical Sciences 57(12): 559-560
Ravsten, D.V.; Smith, N.B.; Thatcher, G.W. 1997: Spontaneous male orgasm in association with venlafaxine American Family Physician 55(5): 1561 1564 1574
Il'ina, N.A. 2008: Velaxin (venlafaxine) in the treatment of anxious depression Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 108(3): 24-28
Goldberg, R.J. 1995: Nefazodone and venlafaxine: two new agents for the treatment of depression Journal of Family Practice 41(6): 591-594
De Moor, R.A.; Mourad, L.; ter Haar, J.; Egberts, A.C. 2003: Withdrawal symptoms in a neonate following exposure to venlafaxine during pregnancy Nederlands Tijdschrift Voor Geneeskunde 147(28): 1370-1372
Ansary, A.; Ibhanesebhor, S.; Manjunatha, C. 2014: Myoclonic seizures in a preterm baby: is this a presentation of venlafaxine withdrawal? Singapore Medical Journal 55(4): E57-E59
Ninan, P.T.; Knight, B.; Kirk, L.; Rothbaum, B.O.; Kelsey, J.; Nemeroff, C.B. 1998: A controlled trial of venlafaxine in trichotillomania: interim phase I results Psychopharmacology Bulletin 34(2): 221-224
Hanekamp, B.B.; Zijlstra, J.G.; Tulleken, J.E.; Ligtenberg, J.J.M.; van der Werf, T.S.; Hofstra, L.S. 2005: Serotonin syndrome and rhabdomyolysis in venlafaxine poisoning: a case report Netherlands Journal of Medicine 63(8): 316-318